Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the length of time and extent of blood pressure
response to minoxidil and hydralazine among cancer patients with difficult-to-treat vascular
endothelial growth factor (VEGF) inhibitor treatment induced hypertension.